Tenon Medical, Inc. (TNON)
USD 1.85
(-3.14%)
USD 1.85
(-3.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -12.18 Million | -12.02 Million | -4.29 Million | -167.36 Thousand | -235.2 Thousand |
| Net Income | -15.58 Million | -18.91 Million | -7.08 Million | -705.36 Thousand | -509.58 Thousand |
| Depreciation & Amortization | 426 Thousand | 289 Thousand | 113.98 Thousand | - | - |
| Deferred income taxes | 546 Thousand | - | -2029.00 | - | - |
| Stock-based compensation | 4.14 Million | 2.89 Million | 377 Thousand | 16.64 Thousand | 30.57 Thousand |
| Change in working capital | -1.05 Million | 1.72 Million | 451.86 Thousand | 353.57 Thousand | 268.56 Thousand |
| Other non-cash items | -116.99 Thousand | 1.98 Million | 1.84 Million | 167.78 Thousand | -150.59 Thousand |
| Investing Cash Flow | 6.14 Million | -2.88 Million | -4.5 Million | - | 64.48 Thousand |
| Investments in PPE | -361 Thousand | -847 Thousand | -102.41 Thousand | - | - |
| Acquisitions | -6.5 Million | 2.03 Million | - | - | - |
| Investment purchases | -493 Thousand | -10.11 Million | -4.4 Million | - | - |
| Sales/Maturities of investments | 6.99 Million | 8.07 Million | - | - | - |
| Other Investing Activities | 6.5 Million | -2.03 Million | -4.4 Million | - | - |
| Financing Cash Flow | 6.3 Million | 14.11 Million | 11.46 Million | 254.8 Thousand | 321.3 Thousand |
| Debt repayment | -1.25 Million | - | -244.8 Thousand | -276.62 Thousand | -321.3 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 5.56 Million | 14.11 Million | -286.69 Thousand | - | - |
| Other Financing Activities | 5.05 Million | 14.11 Million | 12 Million | 531.42 Thousand | 321.3 Thousand |
| Accounts receivables | -290 Thousand | -152 Thousand | -61.13 Thousand | 39.35 Thousand | -53.38 Thousand |
| Accounts payables | -117 Thousand | 72 Thousand | 443.85 Thousand | 141.28 Thousand | 271.34 Thousand |
| Inventory | -139 Thousand | -227 Thousand | -145.09 Thousand | 18.25 Thousand | -61.54 Thousand |
| Other working capital | -627 Thousand | 2.02 Million | 214.24 Thousand | 154.67 Thousand | 112.15 Thousand |
| Cash at beginning of period | 2.12 Million | 2.91 Million | 245.63 Thousand | 151.96 Thousand | - |
| Cash at end of period | 2.42 Million | 2.12 Million | 2.91 Million | 245.63 Thousand | 151.96 Thousand |
| Capital Expenditure | -361 Thousand | -847 Thousand | -102.41 Thousand | - | - |
| Effect of forex changes on cash | 38 Thousand | 7000.00 | -1990.00 | 6230.00 | 1373.00 |
| Net cash flow / Change in cash | 299 Thousand | -788 Thousand | 2.67 Million | 93.66 Thousand | 151.96 Thousand |
| Free Cash Flow | -12.54 Million | -12.87 Million | -4.39 Million | -167.36 Thousand | -235.2 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.82 Million | -3.57 Million | -15.58 Million | -3.13 Million | -3.33 Million | -4.28 Million |
| Depreciation & Amortization | 150 Thousand | 160 Thousand | 426 Thousand | 151 Thousand | 104 Thousand | 91 Thousand |
| Deferred income taxes | - | - | 546 Thousand | -1.43 Million | -1.5 Million | -1.69 Million |
| Stock-based compensation | 1.03 Million | 1.01 Million | 4.14 Million | 981 Thousand | 1.07 Million | 1.05 Million |
| Change in working capital | 186 Thousand | 50 Thousand | -1.17 Million | -276 Thousand | -995 Thousand | -36 Thousand |
| Other non-cash items | 646 Thousand | 1.65 Million | 5.54 Million | 1.43 Million | 1.5 Million | 1.69 Million |
| Investing Cash Flow | - | -119 Thousand | 6.14 Million | -92 Thousand | 436 Thousand | 1.12 Million |
| Investments in PPE | - | -119 Thousand | -361 Thousand | -92 Thousand | -57 Thousand | -128 Thousand |
| Acquisitions | - | - | -6.5 Million | 1.25 Million | - | -1.25 Million |
| Investment purchases | - | - | -493 Thousand | - | - | -493 Thousand |
| Sales/Maturities of investments | - | - | 6.99 Million | - | 493 Thousand | 1.75 Million |
| Other Investing Activities | - | - | 6.5 Million | -1.25 Million | 493 Thousand | 1.25 Million |
| Financing Cash Flow | - | 4.37 Million | 6.3 Million | 1.37 Million | 266 Thousand | 4.7 Million |
| Debt repayment | - | - | -1.25 Million | -1.25 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 4.37 Million | 5.56 Million | 300 Thousand | 453 Thousand | 4.8 Million |
| Other Financing Activities | - | 1.93 Million | -509 Thousand | -179 Thousand | -187 Thousand | -101 Thousand |
| Accounts receivables | -144 Thousand | -63 Thousand | -290 Thousand | 255 Thousand | -172 Thousand | -285 Thousand |
| Accounts payables | 845 Thousand | -167 Thousand | -117 Thousand | -330 Thousand | -149 Thousand | -16 Thousand |
| Inventory | 23 Thousand | -78 Thousand | -139 Thousand | -80 Thousand | 96 Thousand | -154 Thousand |
| Other working capital | -538 Thousand | 358 Thousand | -627 Thousand | -121 Thousand | -770 Thousand | 419 Thousand |
| Cash at beginning of period | 4.38 Million | 2.42 Million | 2.12 Million | 3.37 Million | 5.85 Million | 3.17 Million |
| Cash at end of period | 1.96 Million | 4.38 Million | 2.42 Million | 2.42 Million | 3.37 Million | 5.85 Million |
| Capital Expenditure | - | -119 Thousand | -361 Thousand | -92 Thousand | -57 Thousand | -128 Thousand |
| Effect of forex changes on cash | - | 46 Thousand | 38 Thousand | 56 Thousand | -30 Thousand | 13 Thousand |
| Net cash flow / Change in cash | -2.42 Million | 1.96 Million | 299 Thousand | -943 Thousand | -2.48 Million | 2.67 Million |
| Free Cash Flow | -2.42 Million | -2.45 Million | -12.54 Million | -2.37 Million | -3.21 Million | -3.3 Million |
FGP
MIO
600301
PGSUS
LAND
ARV